Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Claxton

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
BMJ Global Health|September 2, 2020
Practical metrics for establishing the health benefits of research to support research prioritisationBeth Woods, Laetitia Schmitt, Claire Rothery, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 29, 2010
Value for money and the Quality and Outcomes Framework in primary care in the UK NHSSimon Walker, Anne R Mason, Karl Claxton, et al.
Journal of Health Services Research & Policy|January 25, 2007
Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical ExcellenceAnthony Culyer, Christopher McCabe, Andrew Briggs, et al.
Applied Health Economics and Health Policy|April 9, 2025
Guiding Health Resource Allocation: Using Population Net Health Benefit to Align Disease Burden with Cost Effectiveness for Informed Decision MakingMegha Rao, Simon Walker, Karl Claxton, et al.
Health Economics|December 21, 2005
Discounting and cost-effectiveness in NICE - stepping back to sort out a confusionKarl Claxton, Mark Sculpher, Anthony Culyer, et al.
BMJ (Clinical Research Ed.)|June 5, 2010
Continuing the multiple sclerosis risk sharing scheme is unjustifiedChristopher McCabe, Jim Chilcott, Karl Claxton, et al.
Health Economics|March 1, 2005
Probabilistic sensitivity analysis for NICE technology assessment: not an optional extraKarl Claxton, Mark Sculpher, Chris McCabe, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
A Comprehensive Algorithm for Approval of Health Technologies With, Without, or Only in Research: The Key Principles for Informing Coverage DecisionsKarl Claxton, Stephen Palmer, Louise Longworth, et al.
BMJ Global Health|April 18, 2018
Supporting the development of a health benefits package in MalawiJessica Ochalek, Paul Revill, Gerald Manthalu, et al.
Applied Health Economics and Health Policy|February 10, 2006
Should patients have a greater role in valuing health states?John Brazier, Ron Akehurst, Alan Brennan, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
BMJ Global Health|September 2, 2020
Practical metrics for establishing the health benefits of research to support research prioritisationBeth Woods, Laetitia Schmitt, Claire Rothery, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 29, 2010
Value for money and the Quality and Outcomes Framework in primary care in the UK NHSSimon Walker, Anne R Mason, Karl Claxton, et al.
Journal of Health Services Research & Policy|January 25, 2007
Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical ExcellenceAnthony Culyer, Christopher McCabe, Andrew Briggs, et al.
Applied Health Economics and Health Policy|April 9, 2025
Guiding Health Resource Allocation: Using Population Net Health Benefit to Align Disease Burden with Cost Effectiveness for Informed Decision MakingMegha Rao, Simon Walker, Karl Claxton, et al.
Health Economics|December 21, 2005
Discounting and cost-effectiveness in NICE - stepping back to sort out a confusionKarl Claxton, Mark Sculpher, Anthony Culyer, et al.
BMJ (Clinical Research Ed.)|June 5, 2010
Continuing the multiple sclerosis risk sharing scheme is unjustifiedChristopher McCabe, Jim Chilcott, Karl Claxton, et al.
Health Economics|March 1, 2005
Probabilistic sensitivity analysis for NICE technology assessment: not an optional extraKarl Claxton, Mark Sculpher, Chris McCabe, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
A Comprehensive Algorithm for Approval of Health Technologies With, Without, or Only in Research: The Key Principles for Informing Coverage DecisionsKarl Claxton, Stephen Palmer, Louise Longworth, et al.
BMJ Global Health|April 18, 2018
Supporting the development of a health benefits package in MalawiJessica Ochalek, Paul Revill, Gerald Manthalu, et al.
Applied Health Economics and Health Policy|February 10, 2006
Should patients have a greater role in valuing health states?John Brazier, Ron Akehurst, Alan Brennan, et al.
Pageof 12